223 related articles for article (PubMed ID: 27633132)
1. Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest.
Wang P; Ye JA; Hou CX; Zhou D; Zhan SQ
Oncol Rep; 2016 Nov; 36(5):2544-2552. PubMed ID: 27633132
[TBL] [Abstract][Full Text] [Related]
2. PPM1D silencing by lentiviral-mediated RNA interference inhibits proliferation and invasion of human glioma cells.
Wang P; Rao J; Yang H; Zhao H; Yang L
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):94-99. PubMed ID: 21336731
[TBL] [Abstract][Full Text] [Related]
3. Association between SOX9 and CA9 in glioma, and its effects on chemosensitivity to TMZ.
Xu X; Wang Z; Liu N; Cheng Y; Jin W; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
Int J Oncol; 2018 Jul; 53(1):189-202. PubMed ID: 29749469
[TBL] [Abstract][Full Text] [Related]
4. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.
Wang Q; Qian J; Wang J; Luo C; Chen J; Hu G; Lu Y
J Neurooncol; 2013 Mar; 112(1):73-82. PubMed ID: 23292182
[TBL] [Abstract][Full Text] [Related]
6. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways.
Wu Y; Dong L; Bao S; Wang M; Yun Y; Zhu R
Biomed Pharmacother; 2016 Dec; 84():462-469. PubMed ID: 27685789
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Src enhances the cytotoxic effect of temozolomide through AKT in glioma.
Wang Z; Sun J; Li X; Yang S; Yue S; Zhang J; Yang X; Zhu T; Jiang R; Yang W
Oncol Rep; 2013 Apr; 29(4):1395-8. PubMed ID: 23338526
[TBL] [Abstract][Full Text] [Related]
8. FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.
Lin J; Ji A; Qiu G; Feng H; Li J; Li S; Zou Y; Cui Y; Song C; He H; Lu Y
Cancer Sci; 2018 Apr; 109(4):1001-1011. PubMed ID: 29427543
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
[TBL] [Abstract][Full Text] [Related]
10. MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway.
Xu P; Zhang G; Hou S; Sha LG
Biomed Pharmacother; 2018 Oct; 106():1419-1427. PubMed ID: 30119215
[TBL] [Abstract][Full Text] [Related]
11. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
Sai K; Li WY; Chen YS; Wang J; Guan S; Yang QY; Guo CC; Mou YG; Li WP; Chen ZP
Am J Chin Med; 2014; 42(2):485-503. PubMed ID: 24707876
[TBL] [Abstract][Full Text] [Related]
12. MiR-3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway.
Kong S; Cao Y; Li X; Li Z; Xin Y; Meng Y
J Cell Mol Med; 2020 Apr; 24(8):4677-4686. PubMed ID: 32181582
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein.
Zhitao J; Long L; Jia L; Yunchao B; Anhua W
Tumour Biol; 2015 Dec; 36(12):9621-30. PubMed ID: 26142735
[TBL] [Abstract][Full Text] [Related]
15. Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe.
Pérès EA; Gérault AN; Valable S; Roussel S; Toutain J; Divoux D; Guillamo JS; Sanson M; Bernaudin M; Petit E
Oncotarget; 2015 Feb; 6(4):2101-19. PubMed ID: 25544764
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of Id2 increases chemosensitivity of glioma.
Zhao Z; He H; Wang C; Tao B; Zhou H; Dong Y; Xiang J; Wang L; Luo C; Lu Y; Yu X
Tumour Biol; 2015 Jun; 36(6):4189-96. PubMed ID: 25773386
[TBL] [Abstract][Full Text] [Related]
17. Combination of sonodynamic with temozolomide inhibits C6 glioma migration and promotes mitochondrial pathway apoptosis via suppressing NHE-1 expression.
Chen L; Cong D; Li Y; Wang D; Li Q; Hu S
Ultrason Sonochem; 2017 Nov; 39():654-661. PubMed ID: 28732990
[TBL] [Abstract][Full Text] [Related]
18. Enhanced proapoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand on temozolomide-resistant glioma cells.
Uzzaman M; Keller G; Germano IM
J Neurosurg; 2007 Apr; 106(4):646-51. PubMed ID: 17432717
[TBL] [Abstract][Full Text] [Related]
19. Down-Regulation of AQP4 Expression via p38 MAPK Signaling in Temozolomide-Induced Glioma Cells Growth Inhibition and Invasion Impairment.
Chen Y; Gao F; Jiang R; Liu H; Hou J; Yi Y; Kang L; Liu X; Li Y; Yang M
J Cell Biochem; 2017 Dec; 118(12):4905-4913. PubMed ID: 28569417
[TBL] [Abstract][Full Text] [Related]
20. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
